DexCom EBIT 2010-2024 | DXCM
DexCom annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
- DexCom EBIT for the quarter ending September 30, 2024 was $0.152B, a 26.03% decline year-over-year.
- DexCom EBIT for the twelve months ending September 30, 2024 was $628M, a 24.06% increase year-over-year.
- DexCom 2023 annual EBIT was $0.598B, a 52.79% increase from 2022.
- DexCom 2022 annual EBIT was $0.391B, a 47.18% increase from 2021.
- DexCom 2021 annual EBIT was $0.266B, a 11.25% decline from 2020.
| DexCom Annual EBIT (Millions of US $) |
|
|---|---|
| 2023 | $598 |
| 2022 | $391 |
| 2021 | $266 |
| 2020 | $300 |
| 2019 | $142 |
| 2018 | $-186 |
| 2017 | $-43 |
| 2016 | $-64 |
| 2015 | $-57 |
| 2014 | $-22 |
| 2013 | $-29 |
| 2012 | $-56 |
| 2011 | $-45 |
| 2010 | $-45 |
| 2009 | $-46 |
| DexCom Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2024-09-30 | $152 |
| 2024-06-30 | $158 |
| 2024-03-31 | $101 |
| 2023-12-31 | $217 |
| 2023-09-30 | $206 |
| 2023-06-30 | $128 |
| 2023-03-31 | $47 |
| 2022-12-31 | $125 |
| 2022-09-30 | $148 |
| 2022-06-30 | $77 |
| 2022-03-31 | $41 |
| 2021-12-31 | $1 |
| 2021-09-30 | $118 |
| 2021-06-30 | $101 |
| 2021-03-31 | $46 |
| 2020-12-31 | $104 |
| 2020-09-30 | $94 |
| 2020-06-30 | $68 |
| 2020-03-31 | $34 |
| 2019-12-31 | $102 |
| 2019-09-30 | $56 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-165 |
| 2018-09-30 | $14 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-31 |
| 2017-12-31 | $12 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-14 |
| 2017-03-31 | $-40 |
| 2016-12-31 | $-6 |
| 2016-09-30 | $-19 |
| 2016-06-30 | $-20 |
| 2016-03-31 | $-19 |
| 2015-12-31 | $2 |
| 2015-09-30 | $-42 |
| 2015-06-30 | $-4 |
| 2015-03-31 | $-13 |
| 2014-12-31 | $2 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-6 |
| 2014-03-31 | $-12 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-10 |
| 2013-03-31 | $-11 |
| 2012-12-31 | $-8 |
| 2012-09-30 | $-17 |
| 2012-06-30 | $-15 |
| 2012-03-31 | $-15 |
| 2011-12-31 | $-12 |
| 2011-09-30 | $-13 |
| 2011-06-30 | $-7 |
| 2011-03-31 | $-12 |
| 2010-12-31 | $-10 |
| 2010-09-30 | $-13 |
| 2010-06-30 | $-11 |
| 2010-03-31 | $-11 |
| 2009-12-31 | $-9 |
| 2009-09-30 | $-12 |
| 2009-06-30 | $-13 |
| 2009-03-31 | $-11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.326B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.041B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $191.072B | 99.90 |
| Alcon (ALC) | Switzerland | $45.679B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.790B | 21.92 |
| Edwards Lifesciences (EW) | United States | $39.062B | 24.81 |
| IDEXX Laboratories (IDXX) | United States | $35.479B | 41.78 |
| Waters (WAT) | United States | $22.831B | 33.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.110B | 0.00 |
| STERIS (STE) | Ireland | $21.616B | 24.91 |
| Hologic (HOLX) | United States | $18.294B | 19.30 |
| Sysmex ADR (SSMXY) | Japan | $12.864B | 40.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.499B | 12.83 |
| Globus Medical (GMED) | United States | $10.952B | 27.89 |
| Teleflex (TFX) | United States | $9.082B | 14.49 |
| Penumbra (PEN) | United States | $9.075B | 88.89 |
| Masimo (MASI) | United States | $8.696B | 42.08 |
| Glaukos (GKOS) | United States | $7.816B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.170B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.587B | 26.00 |
| Inari Medical (NARI) | United States | $3.009B | 0.00 |
| TransMedics (TMDX) | United States | $2.886B | 91.47 |
| LivaNova (LIVN) | United Kingdom | $2.804B | 16.18 |
| Veracyte (VCYT) | United States | $2.802B | 84.84 |
| Nihon Kohden (NHNKY) | Japan | $2.648B | 20.12 |
| Elekta AB (EKTAY) | Sweden | $2.286B | 18.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.010B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.912B | 9.99 |
| RxSight (RXST) | United States | $1.776B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.333B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.203B | 79.75 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.938B | 15.95 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.741B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 38.68 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 15.22 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.627B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| Paragon 28 (FNA) | United States | $0.597B | 0.00 |
| AxoGen (AXGN) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.360B | 19.51 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.293B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 19.43 |
| Inogen (INGN) | United States | $0.263B | 0.00 |
| NeuroPace (NPCE) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.158B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.51 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |